InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（5 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
5
T+90 胜率
0%
T+90 平均收益
-46.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Sullivan Lynne Marie, 首席财务官. Director active across 2 companies, notably Unity Biotechnology, Inc.. In total, 10 filings have been published. Split: 1 buy · 5 sells. Total volume traded: €64k. History available since 24 June 2021. The latest transaction was filed on 2 April 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sullivan Lynne Marie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
21,867 股@ US$1.0374.0% 占其流量Common Stock, $0.0001 par valueSEC:0000950170-25-050410:0
65,000 股0Common Stock, $0.0001 par valueSEC:0000950170-25-047746:0
153 股@ US$2.231.2% 占其流量Common Stock, $0.0001 par valueSEC:0000950170-25-014570:0
136 股@ US$1.290.6% 占其流量Common Stock, $0.0001 par valueSEC:0000950170-24-122295:0
139 股@ US$1.530.7% 占其流量Common Stock, $0.0001 par valueSEC:0000950170-24-091964:0
324 股@ US$1.401.5% 占其流量Common Stock, $0.0001 par valueSEC:0000950170-24-077848:0
925 股@ US$6.8922.0% 占其流量Common Stock, $0.0001 par valueSEC:0000899243-22-036537:0
50,000 股0Common Stock, $0.0001 par valueSEC:0000899243-22-006446:0
12,500 股@ US$4.00100.0% 占其流量Common StockSEC:0001213900-21-039439:0
标准退出：2021年10月26日 (T+90)
30,833 股0Common Stock, $0.0001 par valueSEC:0000899243-21-026230:0
10 条申报中的 10 条
About Sullivan Lynne Marie
Sullivan Lynne Marie is Director Financier. She is linked to Unity Biotechnology, Inc. as CFO & Head of Corp. Dev., and to BiomX Inc. as Director. The total number of filings is 10, and, across the sampled recent filings from 2021-06-28 to 2025-04-03, the amounts shown are EUR 42208 for buys and EUR 21759 for sells, with a modal transaction nature of Cession.
